NCT05757115 is a NA clinical trial of Play Skills Training in Play and Playthings, sponsored by Bezmialem Vakif University.

Who is sponsoring NCT05757115?

NCT05757115 is sponsored by Bezmialem Vakif University.

What drugs are being tested in NCT05757115?

Interventions in NCT05757115: Play Skills Training.

What condition does NCT05757115 study?

NCT05757115 studies Play and Playthings.

Is NCT05757115 still recruiting?

NCT05757115 is currently completed. Last updated 6 September 2023.

Last reviewed 2023-09-06 · How we verify

NCT05757115

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation and Development of Playing Skills for Parents With Children With Special Needs

Completed NA Last updated 6 September 2023

What this trial tests

NA trial testing Play Skills Training in Play and Playthings in 17 participants. Completed in 31 August 2023.

Timeline

15 June 2023

Primary endpoint
15 August 2023

31 August 2023

Quick facts

Lead sponsor	Bezmialem Vakif University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	17
Start date	15 June 2023
Primary completion	15 August 2023
Estimated completion	31 August 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Play Skills Training

Conditions studied

Play and Playthings — all drugs for Play and Playthings →

Sponsor

Bezmialem Vakif University

Who can join

Adults 20 to 50, female only, with Play and Playthings. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children with special needs; experiences physical, behavioral, social, cognitive and emotional limitations. These limitations affect the child's play skills. They need to be supported and encouraged by their parents to enable them to participate in the game. Parental playing skills creativity, self-efficacy and active participation are important factors in this regard. In current studies, parents with special needs children; It is supported that there is a relationship between play, acting and parental self-efficacy. In this study, it was aimed to improve the skills of parents with special needs children to play games with their children multidimensionally and to develop these skills with individual-specific techniques. Detailed assessments will be carried out in order to determine the functional, cognitive and psychosocial skills of the parents. After the evaluation phase is completed, the scores of each parent will be analyzed and interpreted according to Occupational Therapy Models. Playing training will be given individually according to parameters such as strong and weak features, strong sensory system, personality traits, predisposition and defensive approaches.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Bezmialem Vakif University trials

Trials by the same sponsor.

NCT07369297 — PULP SENSIBILITY AND MASSETER INHIBITORY REFLEX IN DIABETIC POLYNEUROPATHY · not yet recruiting
NCT07433595 — Association Between Child and Parental Stress and Bruxism in Children Aged 8-11 Years · not yet recruiting
NCT07443111 — Comparison of Virtual Reality-Based and Routine Preoperative Education on Surgical Anxiety and Salivary Cortisol · NA · not yet recruiting
NCT07421349 — Comparison of Pulmonary Functions and Respiratory Muscle Strength Between Children With Hearing Impairment and Healthy P · not yet recruiting
NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05757115 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bezmialem Vakif University
Last refreshed: 6 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05757115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing